RESUMEN
Severe acute respiratory syndrome coronavirus 2 is one of the most impactful diseases experienced in the past century. While the official national health emergency concluded in May of 2023, coronavirus disease 2019 (COVID-19) continues to mutate. As the summer of 2023, all countries were experiencing a new surge of cases from the EG.5 Omicron variant. Additionally, a new genetically distinct Omicron descendant BA2.86 had been detected in multiple countries including the United States. This article seeks to offer lessons learned from the pandemic, summarize best evidence for current management of patients with COVID-19, and give insights into future directions with this disease.
Asunto(s)
COVID-19 , Humanos , COVID-19/epidemiología , SARS-CoV-2Asunto(s)
Herpes Zóster/patología , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Frente/patología , Herpes Zóster/complicaciones , Herpes Zóster/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Infecciones Estafilocócicas/complicaciones , Staphylococcus aureus/aislamiento & purificaciónRESUMEN
This article illustrates the challenges practitioners face evaluating shortness of breath, a common emergency department complaint. Through a series of patient encounters, pitfalls in the evaluation of shortness of breath are reviewed and discussed.